Sep 30, 2011

United Therapeutics Q3 2011 Earnings Report

Total Revenue
$202M
Previous year: $171M
+18.0%
EPS
$1.45
Previous year: $0.71
+104.2%
Gross Profit
$179M
Previous year: $149M
+20.0%
Cash and Equivalents
$344M
Previous year: $210M
+63.7%
Free Cash Flow
$62.8M
Previous year: $98.7M
-36.4%
Total Assets
$1.67B
Previous year: $1.28B
+30.0%

United Therapeutics

United Therapeutics